Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Taguchi

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
Internal Medicine (Tokyo, Japan)|July 9, 2025
Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine MonotherapyTakafumi Furumoto, Koji Ando, Eo Toriyama, et al.
International Journal of Hematology|February 27, 2007
Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, JapanEmi Matsuo, Yasushi Miyazaki, Chizuko Tsutsumi, et al.
Leukemia Research|November 23, 2013
Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study GroupHidehiro Itonaga, Hideki Tsushima, Daisuke Imanishi, et al.
International Journal of Hematology|March 7, 2009
Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study GroupMari Sakai, Yasushi Miyazaki, Emi Matsuo, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
Internal Medicine (Tokyo, Japan)|July 9, 2025
Efficacy of Azacitidine Plus Venetoclax in Acute Myeloid Leukemia Transformed from Myelodysplastic Syndrome after Failure of Azacitidine MonotherapyTakafumi Furumoto, Koji Ando, Eo Toriyama, et al.
International Journal of Hematology|February 27, 2007
Imatinib provides durable molecular and cytogenetic responses in a practical setting for both newly diagnosed and previously treated chronic myelogenous leukemia: a study in nagasaki prefecture, JapanEmi Matsuo, Yasushi Miyazaki, Chizuko Tsutsumi, et al.
Leukemia Research|November 23, 2013
Molecular analysis of the BCR-ABL1 kinase domain in chronic-phase chronic myelogenous leukemia treated with tyrosine kinase inhibitors in practice: study by the Nagasaki CML Study GroupHidehiro Itonaga, Hideki Tsushima, Daisuke Imanishi, et al.
International Journal of Hematology|March 7, 2009
Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size: a report by the Nagasaki CML Study GroupMari Sakai, Yasushi Miyazaki, Emi Matsuo, et al.
Pageof 16